The AbC-19™ range are COVID-19 rapid antibody tests that detect IgG antibodies (including neutralising antibodies) to the SARS-CoV-2 trimeric spike protein.
AbC-19™ Rapid Test confirms the presence or absence of IgG antibodies following infection or vaccination. While AbC-19™ Semi-Q Rapid Test produces semi-quantitative results via a line intensity scorecard for monitoring COVID-19 antibody status over time.
Detecting IgG antibodies to the SARS-CoV-2 trimeric spike protein correlates with neutralising activity, confirming immune response and providing the end user with peace-of-mind on their antibody status.
The UK-Rapid Test Consortium (UK-RTC) was set up by Abingdon Health to bring together scientists and medical device manufacturers to be able to deliver millions of test kits as quickly as possible following the SARS-CoV-2 outbreak. By working together, some of the UK’s leading medical technology companies will deliver more volume more quickly to help fight COVID-19.
We would be really pleased to chat to you – as an initial step, please fill out the form below and a member of our team will contact you.